The 18-month field study, which began in November 2024, includes Spain, France, Romania, and Germany. In the Ulm area alone, 13 secondary schools have already joined, with a total of 16 expected to participate. Around 3,000 students from grades 7 to 13 in each country will be surveyed.
Dr. Ann-Marie Küchler from Ulm University, coordinating the German field trial, notes: "To evaluate effectiveness, we will compare an intervention group with a waiting list group that will have access to the IMPROVA platform one school year later."
MEDICA-tradefair.com; Source: Ulm University